Vivus says impotence drug data good; shares rise
Thu, 23 Jun 2005 12:17 PM EST
... CHICAGO (Reuters) - An experimental impotence drug being developed by Vivus Inc. showed promise in promoting sex in a mid-stage clinical trial, the company said on Thursday, pushing shares up 12 percent in premarket trading. ...
Related Topics
- Impotence
- Data & Statistics
- Data Analysis
- National Data
- Mining
- Drug Safety
- Prescription Drugs
- Drug Side Effects
- Erectile Disorder (Impotence)
- Drug Abuse
- Drug Information
- Prescription Drug Abuse
- Prescription Drugs Abuse
- Microbes
- Logging
- Erectile Dysfunction
- Chemical Safety
- Visualization
- S-adenosyl methionine (SAM-e)
- Influenza Surveillance Data

Not Signed In -


